Home > Advanced Proteome Therapeutics Salary

Advanced Proteome Therapeutics Salary

  • 55
  • 67
  • 66
Advanced Proteome Therapeutics average salary is $61,317, median salary is $61,317 with a salary range from $50,500 to $72,134.
Advanced Proteome Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Advanced Proteome Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Total 2 Advanced Proteome Therapeutics Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More info
Real Estate Acquisition Analyst 72,134-72,134 Skokie, IL, 60076 2015 Advanced Proteome Therapeutics Real Estate Acquisition Analyst Salaries (2)
Advanced Proteome Therapeutics Skokie, IL Salaries
Real Estate Acquisition Analyst 50,500-50,500 Skokie, IL, 60076 2014 Advanced Proteome Therapeutics Real Estate Acquisition Analyst Salaries (2)
Advanced Proteome Therapeutics Skokie, IL Salaries
Calculate how much you could earn

It's FREE. Based on your input and our analysis.     How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address

Advanced Proteome Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Calculate Your Salary Ranking
Advanced Proteome Therapeut... Jobs
See more Advanced Proteome Therapeutics Jobs»
Search All Jobs

JobCompare – Find open jobs faster
Patents information
Advanced Proteome Ther... Information
  • Advanced Proteome Therapeutics Inc.
  • Industry: BioTech/Drugs
  • City: Boston, MA
  • The revolution in genomics and proteomics spawned by the human genome project is providing a steady stream of protein therapeutic candidates. Many of these proteins require enhancements in their pharmacokinetic properties in order to be clinically effective because of inherent limitations of proteins as drugs. Advanced Proteome Therapeutics has initiated a program that is broadly applicable to proteins. It builds on a technology platform developed over twenty years of targeting proteins for site-selective modification and addresses issues which limit therapeutic utilization of promising proteins